Ventral anterior homeobox 2 (VAX2)

**Ventral anterior homeobox 2 (VAX2)** is a homeobox transcription factor primarily expressed during embryonic development in the ventral retina and forebrain[1][2][3][4][5][7]. It is essential for ventral eye specification, morphogenesis, and correct formation of the optic fissure. VAX2 represses the expression of other transcription factors such as PAX6, thereby guiding the structural and functional patterning of the developing eye[3][4][7]. In human diseases, VAX2 dysregulation or epigenetic alteration has been implicated in various cancers, where its promoter methylation status or expression level can serve as a disease marker[1][2]. Its precise spatiotemporal activity is regulated by post-translational phosphorylation, which affects subcellular localization and stabilization[3]. VAX2 variants have also been associated with craniofacial defects (such as cleft lip/palate) and retinal dystrophies. While not a typical direct therapeutic target (such as a classical receptor or enzyme), its role as a transcriptional and developmental regulator is of substantial research and diagnostic interest[1][2][3][4][5][7].

Other names

DRES93ventral anterior homeobox 2VAX2

Not directly drugged; mechanisms described involve transcriptional regulation, epigenetic regulation (e.g., promoter methylation in tumors), and gene expression modulation[1][2][5].